Reducing annotation burden in medical imaging with ADGNET: A semi-supervised deep learning strategy
Clinical Snapshot
PICO Framework
| P — Population | MRI datasets for Alzheimer's disease diagnosis (KACD: 6,400 2D images, ROAD: 532 3D scans) |
| I — Intervention | ADGNET semi-supervised deep learning framework with joint image reconstruction and classification |
| C — Comparator | State-of-the-art methods (ResNeXt WSL, SimCLR) |
| O — Outcomes | Diagnostic performance across six metrics, interpretability analysis, correlation with AD pathology |
Bottom Line
ADGNET represents a promising semi-supervised deep learning approach for Alzheimer's disease diagnosis from MRI that addresses the practical challenge of limited annotated training data. The framework demonstrates meaningful performance improvements over existing methods and shows clinically relevant focus on hippocampal and temporal regions. However, this remains an early-stage technical development requiring substantial clinical validation before implementation. Key limitations include lack of prospective clinical testing, unknown generalizability to diverse patient populations, and absence of comparison with current diagnostic workflows. While the interpretability features are encouraging, clinicians should await rigorous clinical trials and regulatory approval before considering adoption. The approach may eventually support radiological interpretation but cannot replace comprehensive clinical assessment for dementia diagnosis.
Key Findings
P Value: p < 0.001 for correlation with AD pathology
Effect Size: 4.1% improvement (KACD dataset), 7.2% improvement (ROAD dataset)
Primary Outcome: Diagnostic performance improvement over state-of-the-art methods
Nnt Or Sensitivity: Correlation coefficient r = 0.67 with established AD pathology markers
Confidence Interval: Not reported
Clinical Application
Requires specialized computational infrastructure and technical expertise for implementation Could support PBS-funded MRI interpretation and complement RACGP dementia assessment guidelines, pending TGA approval for clinical use Patients undergoing MRI evaluation for suspected Alzheimer's disease
Abstract
We propose ADGNET, a semi-supervised framework for Alzheimer's disease (AD) diagnosis that jointly optimizes image reconstruction and classification through shared feature representations. The architecture integrates a residual backbone with attention modulation for dynamic feature selection, an encoder-decoder reconstruction branch for unsupervised representation learning, and a classification branch with focal loss to address class imbalance. This dual-task design enables effective feature learning from limited annotations. On two public MRI datasets-KACD (2D, 6,400 images) and ROAD (3D, 532 scans)-ADGNET achieves average performance improvements of 4.1% and 7.2% over state-of-the-art methods (ResNeXt WSL, SimCLR) across six metrics. Interpretability analysis using Grad-CAM and attention visualization confirms that the model focuses on clinically relevant neuroanatomical structures, particularly the hippocampus and temporal lobes, with strong correlation to established AD pathology (r = 0.67, p < 0.001). These results validate the model's exceptional generalization capability and feature representation effectiveness across multi-modal medical imaging data, offering an efficient solution for few-shot medical image analysis.
References
- 1.Yang, X. (2026). Reducing annotation burden in medical imaging with ADGNET: A semi-supervised deep learning strategy. PLoS One. https://doi.org/10.1371/journal.pone.0348596
Related Research
Sleep medicine reviews
Machine and deep learning in REM sleep behavior disorder: a scoping review and analysis of reporting quality
3 Aug 2026
Neurological research
Federated deep learning model for epilepsy seizure detection using electroencephalogram (EEG) signal
2 Aug 2026
Journal of psychiatric research
Systematic review of machine learning and deep learning models for EEG-based detection of depression.
2 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service